Buy The Dip On Bristol-Myers Squibb: J.P. Morgan

By: via Benzinga
In a report published Tuesday, JP Morgan analyst Chris Schott maintained an Overweight rating on Bristol-Myers Squibb Co (NYSE: BMY), ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.